D. Ehlert, Joshua Bird, D. Bergey, Valerie Bentivegna, Brandon Keehner, R. Milner, Rachel Simons
{"title":"TriSalus: SD-101和SmartValve技术","authors":"D. Ehlert, Joshua Bird, D. Bergey, Valerie Bentivegna, Brandon Keehner, R. Milner, Rachel Simons","doi":"10.1145/3577024.3588877","DOIUrl":null,"url":null,"abstract":"TriSalus's investigational therapeutic candidate SD-101 has the potential to reprogram or eliminate immunosuppressive cells and enable immunotherapy in liver tumors.","PeriodicalId":362354,"journal":{"name":"Proceedings of the Special Interest Group on Computer Graphics and Interactive Techniques Conference: Electronic Theater","volume":"1965 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"TriSalus: SD-101 and SmartValve Technology\",\"authors\":\"D. Ehlert, Joshua Bird, D. Bergey, Valerie Bentivegna, Brandon Keehner, R. Milner, Rachel Simons\",\"doi\":\"10.1145/3577024.3588877\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"TriSalus's investigational therapeutic candidate SD-101 has the potential to reprogram or eliminate immunosuppressive cells and enable immunotherapy in liver tumors.\",\"PeriodicalId\":362354,\"journal\":{\"name\":\"Proceedings of the Special Interest Group on Computer Graphics and Interactive Techniques Conference: Electronic Theater\",\"volume\":\"1965 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the Special Interest Group on Computer Graphics and Interactive Techniques Conference: Electronic Theater\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1145/3577024.3588877\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the Special Interest Group on Computer Graphics and Interactive Techniques Conference: Electronic Theater","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1145/3577024.3588877","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
TriSalus's investigational therapeutic candidate SD-101 has the potential to reprogram or eliminate immunosuppressive cells and enable immunotherapy in liver tumors.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
